ESR1 and breast carcinoma: Its efficacy was demonstrated through in silico [72,73] and in vivo studies on tumor tissue that had undergone unilateral or bilateral mastectomy [72,74] as well as on athymic nude mice inoculated with BT-474 breast cancer cell line (ERα+, derived from ductal carcinoma) [74].